United Kingdom (UK) Parkinsons Disease Therapeutics Market (2025-2031) | Outlook, Analysis, Segmentation, Value, Forecast, Trends, Industry, Companies, Size & Revenue, Growth, Competitive Landscape, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Parkinsons Disease Therapeutics Market - Industry Life Cycle

3.4 United Kingdom (UK) Parkinsons Disease Therapeutics Market - Porter's Five Forces

3.5 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Parkinson's disease in the UK

4.2.2 Rising geriatric population in the UK

4.2.3 Technological advancements in Parkinson's disease therapeutics

4.2.4 Growing awareness about Parkinson's disease among patients and healthcare professionals

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of Parkinson's disease therapeutics

4.3.2 High cost associated with Parkinson's disease treatment

4.3.3 Side effects associated with current Parkinson's disease medications

4.3.4 Limited availability of specialized healthcare professionals for Parkinson's disease management

6.1 United Kingdom (UK) Parkinsons Disease Therapeutics Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenues & Volume, By Levodopa Combination, 2021- 2031F

6.1.4 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.1.5 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenues & Volume, By MAO-B Inhibitors, 2021- 2031F

6.1.6 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenues & Volume, By COMT Inhibitors, 2021- 2031F

7.1 United Kingdom (UK) Parkinsons Disease Therapeutics Market Export to Major Countries

7.2 United Kingdom (UK) Parkinsons Disease Therapeutics Market Imports from Major Countries

8.1 Average age of diagnosis of Parkinson's disease in the UK

8.2 Number of clinical trials for Parkinson's disease therapeutics conducted in the UK

8.3 Adoption rate of new Parkinson's disease treatment guidelines in the UK

8.4 Patient satisfaction levels with Parkinson's disease management services

8.5 Number of Parkinson's disease support groups and organizations in the UK

9.1 United Kingdom (UK) Parkinsons Disease Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F

10.1 United Kingdom (UK) Parkinsons Disease Therapeutics Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Parkinsons Disease Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters